NDC 59651-427 – Spironolactone
Spironolactone 50 mg/1 · Tablet · Oral
Product NDC59651-427
Product details
- Brand name
- Spironolactone
- Generic name
- Spironolactone
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA202187
- Marketed since
- December 13, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Aldosterone Antagonist
Active ingredients
- Spironolactone 50 mg/1
Uses, dosage, side effects and warnings for Spironolactone →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59651-427-01 | 100 TABLET in 1 BOTTLE (59651-427-01) | Dec 13, 2019 |
| 59651-427-05 | 500 TABLET in 1 BOTTLE (59651-427-05) | Dec 13, 2019 |
Other Spironolactone products
- 50090-7083 Spironolactone 50 mg/1 · Tablet · A-S Medication Solutions
- 50090-0136 Spironolactone 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-6908 Spironolactone 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-6909 Spironolactone 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-7082 Spironolactone 50 mg/1 · Tablet · A-S Medication Solutions
- 60687-465 Spironolactone 25 mg/1 · Tablet · American Health Packaging
- 60687-476 Spironolactone 50 mg/1 · Tablet · American Health Packaging
- 60687-487 Spironolactone 100 mg/1 · Tablet · American Health Packaging
- 65162-511 Spironolactone 25 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 65162-514 Spironolactone 50 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 65162-515 Spironolactone 100 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 53746-514 Spironolactone 50 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC